Cardiovascular pharmacotherapeutic considerations in patients undergoing anesthesia

Cardiology in Review

Volumn 19, Issue 1, 2011, Pages 12-16

  Wolf, Alexander ^a   McGoldrick, Kathryn E ^a  

^a WESTCHESTER MEDICAL CENTER   (United States)

Author keywords

Drug interactions; perioperative hypotension and myocardial ischemia; perioperative risk stratification; rebound hypertension

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; AMIODARONE; ANESTHETIC AGENT; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; CIMETIDINE; CLONIDINE; DANTROLENE; DESFLURANE; DEXMEDETOMIDINE; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESMOLOL; FENTANYL; METOPROLOL; MIVAZEROL; NIFEDIPINE; PHENYTOIN; PROCAINAMIDE; QUINIDINE; RANITIDINE; SEVOFLURANE; SUXAMETHONIUM; THEOPHYLLINE; UNINDEXED DRUG; VERAPAMIL; WARFARIN;

ADJUVANT THERAPY; ANESTHESIA; ANESTHESIA COMPLICATION; ANESTHETIC RECOVERY; CARDIOVASCULAR EFFECT; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR PERFORMANCE; CARDIOVASCULAR RESPONSE; CONGESTIVE HEART FAILURE; DRUG HALF LIFE; DRUG WITHDRAWAL; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTENSION; MALIGNANT HYPERTHERMIA; META ANALYSIS; REVIEW; SYSTEMATIC REVIEW;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ADRENERGIC BETA-ANTAGONISTS; AMIODARONE; ANESTHESIA, GENERAL; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; DIURETICS; HUMANS; PREOPERATIVE PERIOD;

EID: 78650798816     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/CRD.0b013e3182000e11     Document Type: Review

References (42)

1. Chobanian AV, Bakris GL, Black KR, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA. 2003;289:2560-2572.
2. Howell SJ, Sear JW, Foex P. Hypertension, hypertensive heart disease and perioperative risk. Br J Anaesth. 2004;92:570-583. (Pubitemid 38443862)
3. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;1043-1049.
4. Hollenberg M, Mangano DT, Browner WS, et al. The Study of Perioperative Ischemia Group. Predictors of postoperative myocardial ischemia in patients undergoing noncardiac surgery. JAMA. 1992;268:205-209.
5. Abou-Chebl A, Yadav JS, Reginelli JP, et al. Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting: risk factors,prevention and treatment. J Am Coll Cardiol. 2004;43:1596-1601.
6. Aronson S, Boisvert D, Lapp W. Isolated systolic hypertension is associated with adverse outcomes from coronary artery bypass grafting surgery. Anesth Analg. 2002;94:1079-1084.
7. Kinney MA, Warner ME, van Heerden JA, et al. Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection. Anesth Analg.2000;1118-1123.
8. Augoustides JG. Should all antihypertensive agents be continued before surgery? In: Fleisher LA, ed. Evidence-Based Practice of Anesthesiology. 2nd ed. Philadelphia, PA: Saunders Elsevier; 2009:49-54.
9. Horan BF, Prys-Roberts C, Roberts JG, et al. Haemodynamic responses to isoflurane anaesthesia and hypovolaemia in the dog, and their modification by propranolol. Br J Anaesth. 1977;49:1179-1187.
10. Horan BF, Prys-Roberts C, Hamilton WK, et al. Haemodynamic responses to enflurane anaesthesia and hypovolaemia in the dog, and their modification by propranolol. Br J Anaesth. 1977;49:1189-1197.
11. Oxorn D, Knox JW, Hill J. Bolus doses of esmolol for the prevention of perioperative hypertension and tachycardia. Can J Anaesth. 1990;37:206-209.
12. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy. A report of the American College of Cardiology/American Heart Association task force on practice guidelines. Anesth Analg. 2007;104:15-26.
13. Pontén J, Biber B, Bjurö T, et al. β-receptor blocker withdrawal: a perioperative problem in general surgery? Acta Anaesth Scand. 1982;76(suppl):32-37.
14. Pontén J, Biber B, Bjurö T, et al. β-receptor blockade and spinal anesthesia: withdrawal versus continuation of long-term therapy. Acta Anaesth Scand.1982;76(suppl):62- 69.
15. Teichert M, Smet PA, Hofman A, et al. Discontinuation of beta blockers and the risk of myocardial infarction in the elderly. Drug Saf. 2007;30:541-549.
16. Hart GR, Anderson RJ. Withdrawal syndromes and the cessation of antihypertensive therapy. Arch Intern Med. 1981;141:1125-1127.
17. Devereaux PJ, Yang H, Yusuf S, et al. for the POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomized controlled trial. Lancet. 2008;371:1839-1847.
18. Merin RG. Calcium channel blocking drugs and anesthetics: Is the drug interaction beneficial or detrimental? Anesthesiology. 1987;66:111-113.
19. Schlanz KD, Myre SA, Bottorff MB. Pharmacokinetic interactions with calcium channel antagonists (part II). Clin Pharmacokinet. 1991;21:448-460.
20. Rubin AS, Zablocki AD. Hyperkalemia, verapamil, and dantrolene. Anesthesiology. 1987;66:246-249.
21. Henling CE, Slogoff S, Kodali SV, et al. Heart block after coronary artery bypass: effect of chronic administration of calcium-entry blockers and beta blockers. Anesth Analg. 1984;63:515-520.
22. Wijeysundera DN, Beattie WS. Calcium channel blockers for reducing cardiac morbidity after noncardiac surgery: A meta-analysis. Anesth Analg. 2003;97:634-641.
23. Hess W, Meyer C. Haemodynamic effects of nifedipine in patients undergoing coronary artery bypass surgery. Acta Anaesthesiol Scand. 1986;30:614-619. (Pubitemid 17195936)
24. Singh BN, Vaughan-Williams EM. The effects of amiodarone, a new antianginal drug on cardiac muscle. Br J Pharmacol. 1970;39:657-667.
25. Liberman BA, Teasdale SJ. Anesthesia and amiodarone. Can Anaesth J. 1985;32:629-638.
26. Elliott PL, Schauble JF, Rogers MC, et al. Risk of decompensation during anesthesia in presence of amiodarone. Circulation. 1983;68(suppl III):III-1120
27. Chassard D, George M, Guiraud M, et al. Relationship between preoperative amiodarone treatment and complications observed during anesthesia for valvular cardiac surgery. Can J Anaesth. 1990;37:251-254.
28. Ellis JE, Drijvers G, Pedlow S, et al. Premedication with oral and transdermal clonidine provides safe and efficacious postoperative sympatholysis. Anesth Analg. 1994;79:1133-1140.
29. Stuhmeier KD, Mainzer B, Cierpka J, et al. Small, oral dose of clonidine reduces the incidence of intraoperative myocardial ischemia in patients having vascular surgery. Anesthesiology. 1996;85:706-712.
30. Nishina K, Mikawa K, Uesugi T, et al. Efficacy of clonidine for prevention of perioperative myocardial ischemia: a critical appraisal and meta-analysis of the literature. Anesthesiology. 2002;96:323-329.
31. Oliver MF, Goldman L, Julian DG, et al. The European Mivazerol Trial (EMIT). Effect of mivazerol on perioperative cardiac complications during noncardiac surgery in patients with coronary heart disease. Anesthesiology. 1999;91:951-961.
32. Wallace AW, Galindez D, Salahieh A, et al. Effect of clonidine on cardiovascular morbidity and mortality after noncardiac surgery. Anesthesiology.2004;101:284-293.
33. Simic J, Kishineff S, Goldberg R, et al. Acute myocardial infarction as a complication of clonidine withdrawal. J Emerg Med. 2003;25:399-402. (Pubitemid 37488045)
34. Coriat P, Richer C, Douraki T, et al. Influence of chronic angiotensinconverting enzyme inhibition on anesthetic induction. Anesthesiology. 1994; 81:299-307.
35. Pigott DW, Nagle C, Allman K, et al. Effect of omitting regular ACE inhibitor medication before cardiac surgery on haemodynamic variables and vasoactive drug requirements. Br J Anaesth. 1999;83:715-720.
36. Brabant SM, Bertrand M, Eyraud D, et al. The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists. Anesth Analg. 1999;89:1388-1392.
37. Bertrand M, Godet G, Meersschaert K, et al. Should angiotensin II antagonists be discontinued before surgery? Anesth Analg. 2001;92:26-30.
38. Comfere T, Sprung J, Kumar MM, et al. Angiotensin system inhibitors in a general surgical population. Anesth Analg. 2005;100:636-644.
39. Malinowska-Zaprzalka M, Wojewodzka M, Dryi D, et al. Hemodynamic effects of propofol in enalapril-treated hypertensive patients during induction of general anesthesia. Pharmacol Rep. 2005;57:675-678.
40. Gravenstein N. Diuretics. In: Roizen MF, Fleisher LA, eds. Essence of Anesthesia Practice. 2nd ed. Philadelphia, PA: WB Saunders; 2002:519.
41. Wahr JA, Parks R, Boisvert D, et al. Multicenter Study of Perioperative Ischemia Research Group. Preoperative serum potassium levels and perioperative outcomes in cardiac surgery patients. JAMA. 1999;281:2203-2210.
42. Greenberg A. Diuretic complications. Am J Med Sci. 2000;319:10-24.